MX2012000558A - Biomarcador. - Google Patents

Biomarcador.

Info

Publication number
MX2012000558A
MX2012000558A MX2012000558A MX2012000558A MX2012000558A MX 2012000558 A MX2012000558 A MX 2012000558A MX 2012000558 A MX2012000558 A MX 2012000558A MX 2012000558 A MX2012000558 A MX 2012000558A MX 2012000558 A MX2012000558 A MX 2012000558A
Authority
MX
Mexico
Prior art keywords
gastrointestinal cancer
biomarker
acid sequence
biomarkers
engrailed
Prior art date
Application number
MX2012000558A
Other languages
English (en)
Inventor
Richard Morgan
Hardev S Pandha
Original Assignee
Univ Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Surrey filed Critical Univ Surrey
Publication of MX2012000558A publication Critical patent/MX2012000558A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen biomarcadores específicos para cáncer gastrointestinal que comprenden la secuencia de ácidos nucleicos del gen Engreiled-2 (EN2) o la secuencia de aminoácidos de la proteína EN2 codificada. También se describen usos de los biomarcadores en el tratamiento, diagnóstico, monitoreo y formación de imágenes del cáncer gastrointestinal.
MX2012000558A 2009-07-13 2010-07-13 Biomarcador. MX2012000558A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0912190.6A GB0912190D0 (en) 2009-07-13 2009-07-13 Biomarker
PCT/GB2010/001333 WO2011007129A2 (en) 2009-07-13 2010-07-13 Biomarker

Publications (1)

Publication Number Publication Date
MX2012000558A true MX2012000558A (es) 2012-03-29

Family

ID=41057908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000558A MX2012000558A (es) 2009-07-13 2010-07-13 Biomarcador.

Country Status (12)

Country Link
US (1) US20120183554A1 (es)
EP (1) EP2454385A2 (es)
JP (1) JP2012533076A (es)
CN (1) CN102648290A (es)
AU (1) AU2010272370A1 (es)
BR (1) BR112012000911A2 (es)
CA (1) CA2767122A1 (es)
GB (1) GB0912190D0 (es)
IL (1) IL217333A0 (es)
MX (1) MX2012000558A (es)
RU (1) RU2012100904A (es)
WO (1) WO2011007129A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105144179B (zh) * 2013-01-29 2019-05-17 分子健康股份有限公司 用于临床决策支持的系统和方法
CN103761451B (zh) * 2014-01-02 2017-04-05 中国科学院数学与系统科学研究院 基于生物医学大数据的生物标记物组合识别方法和系统
KR102098294B1 (ko) * 2016-11-24 2020-04-07 주식회사 휴벳바이오 질환의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629123B2 (en) * 2003-07-03 2009-12-08 University Of Medicine And Dentistry Of New Jersey Compositions and methods for diagnosing autism
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
KR20090053222A (ko) * 2007-11-22 2009-05-27 한국생명공학연구원 체액 내 대장암 마커로서의 ｃｘｃｌ－１６유전자 및 이를이용한 대장암의 진단 및 치료에의 용도
AU2008334901A1 (en) * 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of lung carcinoma
WO2009092597A2 (en) * 2008-01-23 2009-07-30 Epigenomics Ag Methods and nucleic acids for analyses of prostate cancer

Also Published As

Publication number Publication date
RU2012100904A (ru) 2013-08-20
CN102648290A (zh) 2012-08-22
AU2010272370A1 (en) 2012-02-02
JP2012533076A (ja) 2012-12-20
WO2011007129A2 (en) 2011-01-20
AU2010272370A2 (en) 2012-02-23
WO2011007129A3 (en) 2011-04-14
GB0912190D0 (en) 2009-08-26
EP2454385A2 (en) 2012-05-23
CA2767122A1 (en) 2011-01-20
US20120183554A1 (en) 2012-07-19
IL217333A0 (en) 2012-02-29
BR112012000911A2 (pt) 2016-11-22

Similar Documents

Publication Publication Date Title
EP1888786A4 (en) USE FREE CIRCULATIVE DNA FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF CANCER
WO2012054639A3 (en) Nmr systems and methods for the rapid detection of analytes
IN2012DN04381A (es)
EP2611941A4 (en) GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
WO2008061213A3 (en) Genetic variations associated with tumors
WO2010017515A3 (en) Breast cancer specific markers and methods of use
EP2179037A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
WO2006110599A3 (en) Cacna1e in cancer diagnosis, detection and treatment
EA200970891A1 (ru) Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы
WO2010083385A3 (en) Compounds for reducing drug resistance and uses thereof
WO2007141280A3 (en) Proteins
WO2010096604A3 (en) Uses of cancer-targeting peptides in cancer diagnosis
WO2011073629A3 (en) Cancer diagnosis and treatment
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2011106541A3 (en) Diagnostic methods involving loss of heterozygosity
WO2010132370A3 (en) Soluble tlt-1 for the treatment and diagnosis of sepsis
UA105073C2 (uk) Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень
WO2017027391A3 (en) Genetic abnormalities in plasma cell dyscrasias
WO2011097509A3 (en) Hypoxia-related gene signatures for cancer classification
MX2011006773A (es) Biomarcador.
MX2009004382A (es) Variaciones geneticas asociadas con tumores.
MX2012000558A (es) Biomarcador.
WO2007090125A8 (en) Prognostic factors for anti-hyperproliferative disease gene therapy
WO2012061904A8 (en) Histone protein ubiquitination as a cancer biomarker
EP2738265A3 (en) MHC genes and risk of graft versus host disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal